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In this dissertation, I present two studies on miRNA regulation enabled
by high-throughput sequencing technologies and computational approaches.
In the first study, we attempted to learn a general model for miRNA
targeting principles based on AGO CLIP and CLASH data. We used
discriminative learning on AGO CLIP and CLASH interactions to train a
miRNA target prediction model. Our method combined two SVM classifiers,
one to predict miRNA-mRNA duplexes and a second to learn AGO’s
local sequence preferences and positional bias in 3’UTR isoforms. The
duplex SVM model enabled the prediction of non-canonical target sites and
more accurately resolved miRNA interactions from AGO CLIP data than
previous methods. The binding model was trained using a multi-task
strategy to learn context-specific and common AGO sequence preferences.
The duplex and common AGO binding models together outperformed
existing miRNA target prediction algorithms on held-out binding data. In
the second study, we attempted to characterize the context specificity of
miRNA-mediated regulation of target mRNAs that are co-expressed across
multiple cell types. We explored transcriptome-wide targeting and gene
regulation by miR-155, whose activation-induced expression plays important
roles in innate and adaptive immunity. Through mapping of miR-155
targets using differential AGO iCLIP, mRNA quantification using RNA-Seq,
and 3’UTR usage analysis using polyadenylation (polyA)-Seq in activated
miR-155-sufficient and -deficient macrophages, dendritic cells, T and B
lymphocytes, we have identified numerous miR-155 targets with cellular
context specificity. While alternative cleavage and polyadenylation (ApA)
contributed to differential miR-155 binding in some transcripts, a majority
of identical 3’UTR isoforms were also differentially regulated, suggesting
ApA-independent and cellular context-dependent miR-155-mediated gene
regulation reminiscent of sequence-specific transcription factors. Our study
provides a comprehensive map of miR-155’s regulatory networks in key
immune cell types.
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CHAPTER 1
INTRODUCTION
1.1 Background
1.1.1 Molecular basis of miRNA regulation
MicroRNAs (miRNAs) are 20-24 nt long non-coding RNAs that mediate
post-transcriptional regulation of target mRNAs. Since the discovery of lin-4
miRNA in C. elegans in 1993 [1], more than 20,000 miRNAs have been identified
across eukaryotic organisms [2]. A large proportion of miRNAs are conserved
across species, and they also prefer interactions with conserved mRNA target
sites [3]. Functional studies have revealed that miRNAs play crucial regulatory
roles in numerous developmental processes and diseases [4].
The biogenesis of miRNAs is a tightly regulated multi-step process.
miRNA-encoding genes are first transcribed into primary miRNA (pri-miRNA)
transcripts by RNA polymerase II (Pol II). The microprocessor complex formed
by Drosha, an RNase III family enzyme, and the DGCR8 protein, cleave
the pri-miRNAs into shorter precursor miRNA (pre-miRNA) hairpins in the
nucleus. The pre-miRNAs are then transported into cytoplasm under the
mediation by the exportin XPO5 and the GTP-binding protein Ran. The
pre-miRNAs are then further processed by a complex composed of proteins
Dicer, Argonaute and TRBP. Dicer (another RNase III family enzyme) cleaves
the loop off the hairpin, and the resulting miRNA duplex is then loaded into
Argonaute. In the next step the duplex is unwound and one strand, commonly
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known as “mature miRNA”, remains bound to Argonaute while the other
strand known as “miRNA*” is ejected and subsequently degraded, although in
some cases both strands can be functional. Notably, a small number of miRNAs
are not generated by the canonical pathway described above. For instance,
certain pre-miRNAs are produced from splicing of short introns without being
processed by Drosha [5].
Argonaute (AGO) family proteins and AGO-bound mature miRNAs
together form RNA-induced silencing complexes (RISCs). Protein crystallography
has shown that AGO proteins structures have strikingly high conservation
across species, even between archaea and human [6–8]. AGO proteins are
characterized by four domains: amino-terminal (N), PAZ, MID (middle) and
PIWI [9]. The N domain is involved in loading and unwinding of the miRNA
duplex. The PAZ domain forms a “binding pocket” that specifically anchors
the 3’ end of miRNA, while the MID domain recognizes the 5’ end. The
PIWI domain is structurally similar to RNase H and can function as RNA
endonucleases, although not all AGO proteins possess RNA cleavage activity.
For instance, mammalian genomes encode four AGO proteins AGO1-4, of
which only AGO2 is catalytically active [10]. The retained RNA cleavage
activity of AGO2 has been found to assist the Dicer-independent maturation
process of certain miRNAs, in which pre-miRNA hairpins are directly loaded
into RISC and subsequently cleaved. Examples include the maturation of
miR-451 and miR-486 during mammalian erythroid development [11]. The
Argonaute proteins were subject to regulation by post-translational protein
modification. It has been reported that ubiquitylation of AGO proteins by
TRIM-NHL family proteins modulates miRNA regulation in both C. elegans [12]
and mouse [13]. Recently, it has also been discovered that rapid cycles of AGO2
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phosphorylation and dephosporylation maintain the pool of available AGO2
proteins and are essential for the global efficiency of miRNA regulation [14].
RISC mediates repression of target mRNAs via two mechanisms. A miRNA
can direct slicing of target mRNA when there is extensive base pairing between
miRNA and target site and the miRNA is bound to an AGO protein with RNA
endonuclease activity [15, 16]. This mechanism of miRNA-mediated repression
is common in plants [17] but rarely happens in animals [4]. An alternative
mechanism is dominant in mammalian cells, in which RISC is guided by
partial pairing between miRNA and target, and does not slice target mRNAs.
Instead, RISC recruits the cofactor protein TNRC6 after associating with target
mRNA, which interacts with the polyA-binding protein (PABPC) associated
with mRNA’s polyA tail and also recruits deadenylase complexes PAN2-PAN3
or CCR4-NOT [18]. Both deadenylase complexes shorten the polyA tail, which
results in mRNA destabilization. Moreover, CCR4-NOT complex also reduces
translational efficiency by binding with the decapping complex at the 5’ end of
mRNA. Multiple studies have examined the relative extents of mRNA decay
and translational repression by comparing mRNA and protein levels after
perturbing the expression of miRNAs [19–21]. In most post-embryonic cells,
mRNA destabilization explains the majority (∼66-90%) of the changes in mRNA
expression mediated by miRNAs [22]. Therefore, the expression changes of
target mRNAs after miRNA perturbation are commonly used to estimate the
extent of miRNA-mediated regulation. However, a recent study observed that
translational repression is the predominant consequence of miRNA-mediated
regulation in the early zebrafish embryo [23], which may suggest a switch in
the post-transcriptional regulation program during embryonic development.
In the rest of this thesis, we will focus on the miRNA-mediated regulation
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in mammalian cells involving partial miRNA-target complementarity and
repression of target mRNA expression.
1.1.2 Established principles of miRNA targeting
Before it is possible to directly map miRNA-mRNA interactions in vivo (we
will discuss more details in the next section), most of the knowledge about
miRNA targeting came from miRNA perturbation experiments combined with
sequence analysis. The majority of miRNA target sites that mediate mRNA
repression are within 3’ UTR of transcript, although functional target sites
within coding sequences and 5’UTR have also been observed [24]. miRNA
target recognition is primarily through the Watson-Crick pairing between
miRNA nucleotides 2-7 (known as the “seed” sequence at the 5’ end of the
miRNA) and mRNA target sites. Many of miRNA target sites also have
additional matches to miRNA nucleotide 8, or an A in the target mRNA across
from miRNA nucleotide 1, or both [25]. Moreover, the position-1 A in mRNA
is always preferred regardless of the first nucleotide of miRNA, suggesting that
it does not form base pair with miRNA. This is supported by the structural
biology findings showing that a “pocket” in AGO specifically binds to an A at
this position in mRNA [8]. In addition to matches in the seed region, pairing
with 3’ nucleotides of miRNA, usually at positions 13-16, can also enhance
the stability of miRNA-mRNA interactions [26]. Non-canonical target sites,
which lack a contiguous 6-mer match to the seed region, can also mediate
repression, although in most cases the extent of regulation is significantly
weaker than canonical targets [27–31]. Single-molecule assays have suggested
that AGO initially scans transcript for target sites with complementarity to only
4
nucleotides 2–4 of the miRNA, and the initial transient interaction propagates
into a stable association only when there are more complementary bases [32],
which may help explain the origin of non-canonical targets.
1.1.3 CLIP-Seq and related assays
Crosslinking followed by immunoprecipitation (CLIP) [33] combined with
sequencing enables transcriptome-wide characterization of interactions between
RNA-binding proteins (RBPs) and their RNA targets. In the original protocol,
high-throughput sequencing of RNA isolated by CLIP (HITS-CLIP) [34], cells
are first irradiated with 254 nm UV light, inducing the formation of covalent
bonds between the amino acid residue and RNA nucleotide in direct contact.
Next, the protein-RNA complex is immunoprecipitated with a specific antibody
for the protein of interest. The complex is then subject to stringent washing,
which will disrupt non-specific protein-RNA interactions but preserve the
direct interactions due to the crosslink. Immunoprecipitated RNAs are then
treated with optimized concentration of RNase to generate RBP-protected RNA
fragments. The protein is then removed via proteinase K digestion. Adapters
are ligated to the 5’ and 3’ end of RNA fragments, and the RNA is then reverse
transcribed. The cDNA products are PCR amplified with primers that are
complementary to the 5’ and 3’ adapter sequences and then sequenced.
An alternative CLIP protocol is photoactivatable ribonucleoside-enhanced
CLIP (PAR-CLIP) [28]. In PAR-CLIP, cells are treated with a modified nucleoside
such as 4-thiouridine or 6-thioguanosine, which can be integrated into the
newly transcribed RNAs. The modified RNA bases crosslink more efficiently
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with RBPs at 365nm UV light. Moreover, the modified uridine bases will be
misread by the reverse transcriptase, causing T to C mutations that can be used
to pinpoint the crosslinked sites. PAR-CLIP is restricted to cells in culture that
can efficiently take up the modified nucleosides.
In both PAR-CLIP and HITS-CLIP protocols, there is a possibility that
reverse transcription may stop at nucleotides crosslinked to the remaining
peptide after proteinase K digestion [35]. As a result, truncated cDNAs without
5’ adapter sequences will be produced, which will not be PCR-amplified in
the later steps of CLIP library preparation. This issue can be resolved by
only ligating the 3’ adapter to the crosslinked RNA fragment before reverse
transcription and adding the second adapter afterwards, a strategy that has
been utilized by improved CLIP protocols to capture the truncated cDNAs.
The individual-nucleotide resolution CLIP (iCLIP) protocol [36] uses a reverse
transcription primer containing two inversely oriented adapter sequences
separated by a restriction site. The cDNA product is then circularized and
cleaved at the restriction site, creating a linear sequence with adapters at both
ends. Alternatively, the enhanced CLIP (eCLIP) protocol [37] adds a second
single-stranded DNA adapter after reverse transcription and RNA removal to
allow PCR amplification, in order to avoid the potential loss of material during
the circularization and linearization steps. Besides adding more reads to CLIP
libraries, the truncated cDNAs captured by improved CLIP protocol are also
able to pinpoint the crosslink sites with their 3’ coordinates.
It must be noted, though, that multiple types of biases are present in
CLIP libraries and may distort the data analysis. In vitro biochemical studies
have revealed variations in the crosslinking efficiency for different nucleotides
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and amino acid residues [38]. A comprehensive comparison of experimental
protocols has shown that the choice of RNase and the condition to digest the
RBP-bound RNA has significant impact on the nucleotide conposition of CLIP
reads, due to the distinct preferences of different RNases to cleave after certain
bases [39]. During the PCR amplification step present in all CLIP protocols,
cDNAs in the CLIP library are unevenly amplified [40]. In order to control for
PCR amplification artifacts, it has become a common practice in different CLIP
protocols to include a randomized barcode sequence in the adapter or reverse
transcription primer [27, 36, 37]. Reads aligned to the same genomic coordinate
with identical barcode will be treated as PCR duplicates, while the ones with
different barcodes will be identified as unique cDNAs. Another source of bias
in CLIP libraries is non-specific immunoprecipitations. A study has shown that
a large fraction of RBP binding sites from PAR-CLIP libraries overlap with sites
captured by non-specific FLAG-GFP immunoprecipitations, and that the same
non-specific binding sites are often present in CLIP libraries for different RBPs
[41]. Similar non-specific binding sites are also found in libraries generated by
the newer eCLIP protocol [37]. Therefore, proper control libraries are essential
for correcting systematic biases in CLIP data sets and enabling more accurate
identification of RBP binding sites. Control libraries can be generated using
IgG or other non-specific antibodies [42]. “Size-matched input controls”, which
are pre-immunoprecipitation samples prepared identically to the CLIP libraries,
have also been used as alternative control libraries for non-specific background
binding [37].
An important application of CLIP is mapping the miRNA targets in vivo.
Since AGO proteins are essential components of RISCs, AGO binding sites
captured by CLIP correspond to the binding sites of miRNAs expressed in
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given cell types. The regular CLIP protocol is unable to preserve the pairing
between miRNAs and their target RNAs. To address this issue, multiple
AGO CLIP variants have been developed, namely CLASH [30], iPAR-CLIP
[31], CLEAR-CLIP [43] and ChimP [44]. These protocols all feature the usage
of RNA ligase to ligate the interacting miRNA and target RNA fragment
while both are cross-linked to AGO protein. Successful ligation will generate
chimeric reads containing both the miRNA and mRNA sequences, which can
be then computationally decoupled to reveal the miRNA-mRNA interactions.
Although the ligation efficiency in current protocols are still relatively low
(usually <2% [45]), the ligation-based CLIP variants offer great potential
for miRNA research due to the capability of directly capturing the in vivo
interactions between miRNAs and mRNAs.
1.2 Outline of thesis
This dissertation has two independent chapters that cover the major
contributions of my graduate research. In the first chapter, I present our
novel machine learning algorithm [46] for predicting miRNA targeting based
on AGO CLIP and CLASH datasets. In the second chapter, I present a detailed
computational analysis of the cellular context-specificity of miR-155 across
four key immune cell types, using differential iCLIP between wild-type and
miR-155-deficient primary immune cells isolated from mouse.
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1.2.1 Learning the general principles of miRNA targeting
Recent technologies like AGO CLIP sequencing and CLASH enable direct
transcriptome-wide identification of AGO binding and miRNA target sites,
but the most widely used miRNA target prediction algorithms do not exploit
these data. We present a novel model for miRNA target prediction through
discriminative learning on transcriptome-wide AGO CLIP and CLASH profiles.
Our goal was to learn to accurately predict biochemical miRNA-target site
interactions, rather than the extent of regulation, in order to increase the
sensitivity of miRNA target prediction and learn physiological targeting
rules. As the CLASH protocol captures direct interactions between miRNAs
and mRNAs by ligation, it provides a partially labeled training set of
miRNA-mRNA interactions including many non-canonical pairings, which we
combined with canonical AGO binding sites identified by CLIP. We trained one
support vector machine (SVM) classifier to model the miRNA-mRNA duplexes
and a second SVM to learn AGO’s local sequence preferences in the 3’UTR
and positional bias in 3’UTR isoforms. The duplex SVM model enables the
prediction of both canonical and non-canonical pairings between miRNA and
target sequences and outperforms existing methods for assignment of miRNAs
to AGO binding sites. The AGO binding model is trained using a multi-task
strategy to distinguish between cell type and protocol specific sequence signals
and common AGO sequence preferences. The duplex SVM and common AGO
binding SVM together outperform existing target prediction approaches when
evaluated on held out interaction data.
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1.2.2 Context specificity of miRNA regulation in key immune
cell types
Numerous microRNAs and their target mRNAs are co-expressed across diverse
cell types. However, it is unclear whether they are regulated in a cellular
context-independent or -dependent manner. We sought to address this
question through computational and comparative genome-wide molecular
analyses of RISC bound mRNAs, using individual-nucleotide resolution CLIP
(iCLIP) [36], their 3’UTR usage using PolyA-Seq [47] and miR-155-dependent
repression (RNA-Seq) in four key immune cell types – activated macrophages,
dendritic cells, B cells, and CD4 T cells – isolated from miR-155-sufficient and
deficient mice. The analyses of the resulting datasets revealed notable cellular
context-dependent miR-155 targeting and regulation of gene expression.
While ApA contributed to differential miR-155 binding for some transcripts,
in a larger number of cases, identical 3’UTR isoforms were differentially
regulated across cell types. These results suggest ApA-independent and
cellular context-dependent miR-155-mediated post-transcriptional regulation of
gene expression reminiscent of transcriptional regulation by sequence-specific
transcription factors. Furthermore, our study provides comprehensive
comparative maps of miR-155 regulatory RNA networks as well as global
miRNA-mediated Ago binding and genome-wide 3’UTR usage in key activated
immune cell types.
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CHAPTER 2
LEARNING TO PREDICT MIRNA-MRNA INTERACTIONS FROM AGO
CLIP SEQUENCING AND CLASH DATA
Portions of this chapter first appeared in Lu & Leslie [46] and were written in
collaboration with Christina Leslie1.
2.1 Introduction
Recent high-throughput technologies like AGO CLIP sequencing [27] and
CLASH (crosslinking, ligation, and sequencing of miRNA-RNA hybrids [30])
enable direct biochemical identification of AGO binding and miRNA target sites
transcriptome-wide. The miRNA field has a strong tradition of computationally
leveraging transcriptome-wide data to improve target site prediction, but the
leading miRNA target prediction methods today do not exploit these new
biochemical data. Here we present a systematic approach to learn both
the rules of miRNA-target site pairing and a binding model of AGO’s local
sequence preferences and positional bias in alternative 3’UTR isoforms in order
to accurately predict miRNA-target interactions.
Before it became possible to map AGO-mRNA and miRNA-mRNA
interactions directly, the major advance in miRNA target prediction came from
restricting to predefined classes of miRNA seed matches in 3’UTRs and training
a model to predict mRNA expression changes in miRNA overexpression
experiments. TargetScan [26] was the first algorithm to introduce the strategy of
1As per the Cornell dissertation guidelines, the dissertation can include material that has
been previously published or is soon to be published.
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correlating context features of miRNA seed sites-including flanking AU content,
position in the 3’UTR, and complementarity to the 3’ end of the miRNA-with
extent of target down-regulation in miRNA transfection experiments. Similar
observations were encapsulated in the TargetRank method [48], and these
studies established that rules of miRNA targeting could be statistically decoded
from transcriptome-wide data.
However, new data from AGO CLIP sequencing and CLASH challenge some
of the assumptions of existing prediction strategies. These data confirm the
prevalence of non-canonical target sites lacking complementarity to the miRNA
2-7 (6-mer) seed region and conversely show that even exact miRNA 2-8 (7-mer)
seed matches are often not AGO bound [29]. Meanwhile, most target prediction
methods require strong seeds to avoid false positives. For example, predictions
from TargetScan 7.0 [49] still require either perfect 2–8 seed complementarity
(7-mer-m8 site) or a 2–7 seed with A across from miRNA position 1 (7-mer-1A
site), although AGO CLIP data suggests that 7-mer and 8-mer seeds are found
in only about half of AGO binding sites [29]. The mirSVR method [50], which
also trains on miRNA overexpression experiments, allows up to one mismatch
or G:U wobble in the 6-mer seed region, but in practice few non-canonical
sites are assigned even moderate scores. Therefore, current target prediction
methods may focus on detecting the most effective miRNA sites at the cost
of missing a large proportion of miRNA-mRNA interactions. Furthermore,
training on non-physiological miRNA overexpression experiments may obscure
more subtle targeting rules.
A few studies have developed algorithms to resolve which highly expressed
miRNAs are associated with individual AGO CLIP peaks. For example,
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microMUMMIE is an algorithm for analysis of AGO PAR-CLIP that uses the
location of T-to-C mutations—indicative of the site of cross-linking of the
RNA-binding protein to the RNA in the PAR-CLIP assay—to assign the most
likely canonical seed [51]. Other methods use energy-based duplex prediction to
associate miRNAs with CLIP-mapped target sequences. In particular, MIRZA
uses an unsupervised probabilistic approach to learn parameters of a duplex
alignment model from AGO CLIP peaks, and the duplex model can be used to
make de novo miRNA target site predictions from 3’UTR sequence [52]. Note
that the MIRZA study used the term “non-canonical” to refer to sites lacking
7 or 8 nucleotides of perfect complementarity to the 5’ end of the miRNA;
therefore, their reported non-canonical sites included both perfect 6-mer and
many 7-mer-1A sites. (We will use “non-canonical” exclusively for sites lacking
full complementarity in the 2–7 6-mer seed region.) More recently, MIRZA-G
combined MIRZA duplex quality scores with known context features like
flanking AU content and predicted secondary structure accessibility as well
as conservation, once again to predict extent of down-regulation in miRNA
overexpression experiments [53].
Here we present a novel model for miRNA target prediction through
discriminative learning on transcriptome-wide AGO CLIP and CLASH profiles.
Our goal was to learn to accurately predict biochemical miRNA-target site
interactions, rather than the extent of regulation, in order to increase the
sensitivity of miRNA target prediction and learn physiological targeting
rules. As the CLASH protocol captures direct interactions between miRNAs
and mRNAs by ligation, it provides a partially labeled training set of
miRNA-mRNA interactions including many non-canonical pairings, which we
combined with canonical AGO binding sites identified by CLIP. We trained one
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support vector machine (SVM) classifier to model the miRNA-mRNA duplexes
and a second SVM to learn AGO’s local sequence preferences in the UTR
and positional bias in 3’UTR isoforms. The duplex SVM model enables the
prediction of both canonical and non-canonical pairings between miRNA and
target sequences and outperforms existing methods for assignment of miRNAs
to AGO binding sites. The AGO binding model is trained using a multi-task
strategy to distinguish between cell type and protocol specific sequence signals
and common AGO sequence preferences. The duplex SVM and common AGO
binding SVM together outperform existing target prediction approaches when
evaluated on held out interaction data.
2.2 Methods
2.2.1 Feature representation for duplex and context models
We adapted the feature representation from MIRZA [52] to describe the duplex
structures formed between interacting (miRNA, site) pairs. Three types of
features were included in the representation: (1) the type of base pair (GU,
UG, AU, UA, GC, CG) at each position in the alignment; (2) the bases where
a loop is opened, symmetrically extended or asymmetrically extended in the
duplex structure; (3) binary variables for each position in the miRNA sequence
representing whether it is paired to an mRNA base or not. One major change we
made to the original representation was that the only permissible base pairing of
the first base in the miRNA was with an A in mRNA sequence, so that only an A
across from position 1 would contribute positively to the score. This restriction
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is derived from the observations in previous studies [26].
We described the mRNA sites with two types of UTR features: local
sequence context and global positional context. The sequence context was
represented by positional k-mer features (k = 1, ..., 6) from 30 nt sequences
upstream and downstream of the miRNA seed match and implemented using
two weighted degree string kernels [54]. Three positional context features for
each site were computed as (i) the distance to the nearest stop codon, (ii) the
distance to the next end of a 3’UTR isoform, and (iii) the distance to the previous
end of a 3’UTR isoform and were renormalized with a radial basis kernel. These
local sequence kernel and positional kernel were then combined by summing
kernel matrices.
2.2.2 Training and testing of duplex and context models
We trained the duplex model both on (miRNA, site) examples directly derived
from CLASH interactions and on examples with interactions inferred from
CLIP based on 6-mer seed complementarity. One major advantage of the
miRNA-mRNA duplex representation described above is that the model
weights w can also be used as the parameters for local pairwise alignment
[52]: given the feature description ϕ(miRNA, site) for a duplex alignment, the
alignment score can be described by the additive scoring function w ·ϕ(miRNA,
site). Therefore, by iteratively optimizing the model weights given the currents
alignments and then computing the optimal alignments given current model
weights, we can simultaneously optimize the duplexes and the scoring model.
The initial duplex structure for each (miRNA, site) pair was predicted by
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duplexfold in the ViennaRNA package [55], and the corresponding duplex
feature vectors were then used to train a linear support vector machine (SVM)
classifier. The model weights w were then used as local alignment parameters
to update the duplex structure between the miRNA and mRNA site sequences.
The same process was repeated for 12 iterations, by which point the model
vector had converged, and the final duplex structures and model weights were
used as the duplex model’s output. To compensate for the class imbalance, in
each iteration we only used a fraction of negative examples randomly sampled
from the whole set while using all positive examples. Specifically, we sampled
15 times as many CLASH negatives as CLASH positives, and the same number
of CLIP negatives as CLIP positives.
We applied a regular SVM classifier to the UTR kernel matrix when we
trained the AGO binding model using CLIP training data from a single cell type.
When we combined data sets from multiple cell types, we applied the multi-task
learning approach [56] and treated the different cell types as different but related
learning tasks to address the possibility of cell type specific miRNA targeting
and AGO binding rules as well as protocol specific biases. We implemented the
multi-task SVM as a modification to the kernel matrix:
Kst(x, z) = (µ + δst)K(x, z)
If two examples x and z belong to the same task (in other words, two
sites were from the same cell type), then an extra weight is added to their
product in the kernel matrix to reflect the relationship. The free parameter
µ controls the closeness of task-specific models to the average model, and its
optimal value was determined by five-fold cross-validation. All the machine
learning procedures described above were implemented with Numpy (http:
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//www.numpy.org) and the Shogun machine learning tool box (http://
www.shogun-toolbox.org).
2.3 Results
2.3.1 ChimiRic learns both miRNA-mRNA duplex structures
and AGO binding preferences from CLIP and CLASH
data
ChimiRic’s duplex model is trained on chimeric reads from CLASH data, which
associates a miRNA with a target sequence via chimeric reads and can identify
non-canonical binding sites, and AGO CLIP binding sites containing a 6-mer
seed match (or longer seed) for a single highly expressed miRNA. In the latter
case, differential AGO CLIP-seq analysis suggests that an AGO bound site that
can be associated with a unique miRNA by a canonical 6-mer seed is likely a
binding site for that miRNA.
We used CLASH [30] and AGO PAR-CLIP data [39] in HEK293 cells to train
the duplex model, restricting to the top 59 expressed miRNAs in 21 miRNA
seed families. To compile the training set, sites identified by CLASH chimeric
reads were required to fall within 3’UTRs, contain a sequence within an edit
distance of 1 (substitutions or indels) from a canonical 6-mer seed match for the
interacting miRNA, and also be supported by non-chimeric reads. This filtering
yielded the positive training examples consisting of 1,727 (miRNA, site) pairs
supported by chimeric reads, of which 1,228 were non-canonical interactions,
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together with 11,211 canonical (miRNA, site) examples from AGO CLIP sites
(Figure 2.1a). Canonical miRNA seed matches that are not AGO bound based
on CLIP data, together with (miRNA, site) pairs where an AGO-bound site
is paired with an incorrect miRNA, provided 25,411 negative examples. To
compensate for the class imbalance, we only used a randomly sampled subset
of negative examples in training.
We trained a structural SVM [57] on positive and negative (miRNA,
site) training examples to learn a model for predicting miRNA-site duplex
alignments. Here, the model vector w of the SVM represents the scoring
parameters for local pairwise alignment. SVM training proceeds iteratively,
alternating between obtaining optimal alignments of all training examples
given the current SVM parameters w and updating the model vector w given the
current duplex alignments. The model update step involves solving the SVM
large-margin optimization problem so that the discriminant scores assigned to
positive and negative (miRNA, site) examples have the correct sign and obey
margin constraints, with a hinge loss function to control margin violations.
To define the local alignment scoring system and convert the alignment score
into an SVM discriminant function, we used a parameterization similar to
the energy-based scoring system in MIRZA, namely a match/mismatch score
that depends on the position in the miRNA sequence together with the
nucleotides being aligned and penalties for loop opening and for symmetric and
asymmetric loop extensions. One important difference with MIRZA is that the
chimiRic alignment can only start at position 1 of the miRNA if is it matched
against nucleotide A, which more accurately reflects known determinants of
miRNA targeting.
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Figure 2.1: Overview of the chimiRic prediction model. (A) The first
component of the chimiRic model is the duplex SVM, which learns to predict
and score miRNA-mRNA duplex alignments from CLASH and CLIP-seq data.
Positive (miRNA, site) training examples comprise canonical and non-canonical
pairings identified by chimeric reads in CLASH data (top left) as well as sites
with canonical miRNA seeds supported by AGO CLIP data (bottom left).
Negative (miRNA, site) training examples include sites that are paired with a
different miRNA based on CLASH chimeric read data (top right) or miRNA
seed matches with no AGO CLIP evidence (bottom right). The duplex SVM
learns the parameters for local duplex sequence alignment and predicts optimal
alignments for (miRNA, site) pairs through an iterative training procedure.
(B) The second component of chimiRic is the AGO binding SVM, which uses
features encoding the positional bias of AGO binding sites relative to (possibly
multiple) 3’ ends of transcripts as well as the local positional k-mer sequence
features. Mouse and human ApA atlases based on 3’ end sequencing data
(bottom) provide the coordinates of 3’ ends used in the analysis.
The second component of chimiRic’s scoring system is an SVM classifier that
learns to discriminate the local sequence features and positional bias in 3’UTR
isoforms of true AGO binding sites versus sites that contain 6-mer seed matches
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of highly expressed miRNAs but are not AGO-bound, as determined by CLIP
data (Figure 2.1b). Here we considered two AGO CLIP sequencing data sets, the
human HEK293 PAR-CLIP data set as well as a HITS-CLIP data set in activated
mouse CD4 T cells [29]. The local sequence context of the upstream and
downstream 30 nt regions flanking the 6-mer seed match are represented using
weighted degree kernels [54], which encode position specific k-mers for k = 1 ...
6. The positions of 3’ ends of alternative 3’UTR isoforms were identified from
a human 3’-seq tissue atlas [58] and a mouse PolyA-seq atlas [47]. For each site
in human or mouse, positional information was encoded by a vector of distance
values (measured in nucleotides) to the annotated stop codon and to the nearest
mapped 3’ ends and transformed using a radial basis kernel, and the sum of the
weighted degree kernels and positional radial basis kernel was used to train the
SVM. In order to model differences in AGO binding preferences between the
two data sets—both due to protocol differences and potentially due to cell-type
specific factors influencing AGO occupancy—we used multi-task learning to
train cell-type specific AGO preference models together with a common AGO
binding model (Figure 2.1b). The cell-type specific models are intended to
absorb sequence signals that predict AGO binding in a context-dependent
manner, while the common model can be used for target prediction in any new
context.
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2.3.2 ChimiRic’s duplex model outperforms existing methods
for predicting miRNA-mRNA interactions supported by
chimeric reads
To evaluate chimiRic’s duplex model, we held out from training all HEK293
CLASH interactions for a single miRNA seed family (positive test examples)
together with a collection of targets sites that interact with other miRNAs
based on chimeric read evidence (negative test examples), and we assessed
whether the model could rank the held-out miRNA family’s true target sites
above these other sites. We found that the duplex model could more accurately
discriminate true from false interactions compared to MIRZA [52], an existing
method for learning miRNA-mRNA interactions from CLIP data, based on
area under the ROC curve (auROC) analysis (Figure 2.2a, blue points, p <
3.02e-5, signed rank test). Note that the original MIRZA model was trained
on the same HEK293 PAR-CLIP data set as we used to train the duplex
model. To further evaluate the performance on independent data sets, we then
used the duplex model trained on HEK293 CLIP and CLASH data to predict
miRNA-mRNA interactions supported by chimeric reads from iPAR-CLIP in C.
elegans [31] and CLEAR-CLIP in mouse brain [43]. Again, chimiRic’s duplex
model outperformed MIRZA for the task of ranking observed interactions for
each miRNA seed family above interactions with targets sites of other miRNAs
in both C. elegans (Figure 2.2a, green points, p < 1.45e-2, signed rank test)
and mouse brain (Figure 2.2a, purple points, p < 4.87e-2, signed rank test)
data sets. These results suggest that chimiRic’s miRNA-mRNA duplex model
can generalize across organisms and protocols for mapping miRNA-mRNA
interactions.
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Chi et al., 2012
                      5' UAAGGC-ACGCGGUGAAUGCC    hsa-miR-124                   
                          ||||| |||      |||                      
                   EPB41 CUUCCGGUGCCUA---UACAA    5'                   
                      5' UAAGGC-ACGCGGUGAAUGCC    hsa-miR-124                
                          ||||| ||       |                     
                   MINK1 GUUCCGGUGAUGUAACUCCUC    5'
Loeb et al., 2012
                      5' UUAAUGCUAAUUGUGAUAGGGGU  mmu-miR-155
                         |||| ||    |||||       
                  Cep135 AAUUUCGUAUUACACUCGUACA   5'
                      5' UUAAUGCUAAUUGUGAUAGGGGU  mmu-miR-155
                         |||||:||       |||     
                  Gas2l3 AAUUAUGAACUCUUUUAUAUUCA  5'
                      5' UUAAUGCUAAUUGUGAUAGGGGU  mmu-miR-155               
                         |||| |||      ||:||||                  
                   Rasa2 AAUU-CGAGUUG--CUGUCCCCU  5'                
Helwak et al., 2013
                      5' UAUUG--CACUUGUCCCGGCCUGU hsa-miR-92a
                          ||    |||    |||||||       
                   PCGF5 GUACUCGGUGACACGGGCCGGAUC 5'   
                      5' UAUUGCACUUGUCCCGGCCUGU   hsa-miR-92a
                          |::||||     ||||||   
                    RFFL GUGGCGUG-----GGCCGGGAA   5'
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Figure 2.2: Performance of chimiRic’s duplex model for predicting
miRNA-mRNA interactions supported by chimeric reads. (A) Duplex model’s
performance for predicting the correct interacting miRNA seed family among
miRNA-mRNA interactions supported by CLASH chimeric reads. For each
miRNA seed family tested, all CLASH-supported interactions for miRNAs in
the family are held out from training and form the positive test set; negative
test examples consist of interactions for a collection of miRNAs that are held
out from training in all experiments. Each point represents the held-out auROC
for one of the top 23 miRNA seed families in HEK293 (blue), top 19 miRNA
seed families in C. elegans (green) and top 20 miRNA seed families in mouse
brain (purple). (B) Examples of duplexes predicted by the model for previously
validated non-canonical miRNA-mRNA interactions. Various non-canonical
miRNA-mRNA interaction modes were represented, including GU wobbles,
bulges and mismatches within seed sequences and interactions relying on 3’
base pairing instead of seed pairing.
Previous differential CLIP and CLASH studies have revealed a broad
spectrum of non-canonical miRNA-mRNA interaction modes, including GU
wobbles, bulges and mismatches within seed sequences, and interactions
relying on 3’ base pairing instead of seed pairing [29, 30, 59]. In order to
test whether our duplex model captures some of these known patterns of
non-canonical binding, we predicted duplexes for a variety of non-canonical
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miRNA target sites that have been validated by luciferase assays in previous
studies (Figure 2.2b). Our model have not only correctly identified the
correct interacting miRNA above the other highly expressed miRNAs, despite
the lack of exact 6-mer seed matches, but also produced duplex structures
representative of the previously described interaction modes, including GU
wobbles, mismatches and bulges in the seed region, and complementary base
pairings in the 3’ region (Figure 2.2b).
2.3.3 The full chimiRic model outperforms traditional target
prediction for discriminating CLIP-supported miRNA
binding sites
Next we combined the duplex model with the AGO binding model, which
is trained to discriminate between true AGO bound sites containing 6-mer
seeds for highly expressed miRNAs and sites with 6-mer seeds that are not
supported by AGO CLIP read evidence, based both on local sequence context
and positional bias within 3’UTR isoforms. We used a multi-task strategy to
train on AGO-bound versus unbound canonical seed sites for highly expressed
miRNAs in two AGO CLIP data sets, HEK293 PAR-CLIP [39] and HITS-CLIP in
mouse CD4 T cells [29]. This procedure learned both task-specific SVM models
of AGO binding and a common SVM model. The task-specific SVMs may
capture protocol-specific CLIP biases and/or cell-type specific AGO binding
preferences. For target prediction in a new context where no CLIP data is
available, the common SVM provides a “cell-type agnostic” model of AGO
sequence and position preferences.
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Figure 2.3: Performance comparison between chimiRic and other methods
for discriminating AGO bound sites from unbound sites. (A) Examples of
precision-recall curves for discriminating AGO-bound canonical target sites
from seeds with no AGO support for a single miRNA family (miR-30) in
HEK293 and CD4 T cell. Curves correspond to task-specific (T cell: blue;
HEK293: green) and common (purple) AGO binding models, TargetScan
(grey) and mirSVR (black). (B, C) Performance of TargetScan, mirSVR and
task-specific/common AGO binding models on held-out miRNA families in
HEK293 and CD4 T cells measured by auPR. Crossbars represent the median
auPR of each model. (D) Performance of TargetScan, mirSVR and the common
AGO binding model on the top miRNA families in an independent HeLa
CLIP-seq data set measured by auPR. Crossbars represent the median auPR
of each model. (E) Performance of MIRZA-G (grey), MirTarget (black),
DIANA-microT-CDS (blue) and the common AGO binding model (purple) on
the top miRNA families in an independent HeLa CLIP-seq data set measured
by auPR. Crossbars represent the median auPR for each model.
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To evaluate the combined chimiRic model, for each miRNA seed family,
we held out all HEK293 positive target site sequences—both canonical and
non-canonical sites supported by chimeric reads from CLASH as well as
canonical sites with AGO CLIP read evidence that can be unambiguously
assigned to the seed family—and negative site sequences, for training both the
duplex and AGO binding models. We then asked how well the combined model
performs at discriminating AGO-bound from unbound canonical sites relative
to TargetScan [49] and mirSVR [50], two widely used miRNA target prediction
algorithms. Figure 2.3a shows precision-recall curves for the combined chimiRic
duplex and HEK293-specific AGO binding model as well as for TargetScan and
mirSVR for prediction of canonical sites for several miRNA families. Since
TargetScan requires greater seed complementarity than the canonical 6-mer
seed (either 7-mer 1A or complementary at miRNA positions 2–8), its overall
recall of biochemically-defined sites is limited (note that while the TargetScan
7.0 release discusses 6-mer seeds and non-canonical seeds [49], only a very
small fraction of sites were non-canonical in the prediction download files).
Evaluating performance by area under the precision-recall curve (auPR) across
held-out miRNA seed families showed that this performance advantage was
significant over TargetScan (Figure 2.3b, p < 1.91e-6, signed rank test) and
mirSVR (Figure 2.3b, p < 9.54e-6, signed rank test). Moreover, even measuring
performance up to 50% recall (auPR50), where there are still AGO-bound 7-mer
sites to detect, chimiRic still outperformed TargetScan on held-out miRNAs
in the HEK293 and CD4 T cell data sets. We then tested the combination of
chimiRic’s duplex model and the common AGO binding model. Again we
found that chimiRic significantly out-performed TargetScan (Figure 2.3b, p <
1.91e-6, signed rank test) and mirSVR (Figure 2.3b, p < 4.77e-5, signed rank
25
test) on held-out miRNA seed families in HEK293, with minor difference in
chimiRic’s performance compared to the HEK293-specific model. Similarly,
when predicting the biochemically defined target sites of held-out miRNA
families in CD4 T cells, chimiRic’s duplex model combined with either the
T cell specific or the common AGO binding model outperformed TargetScan
on held-out miRNAs in the HEK293 and T cell data sets. We then tested the
combination of chimiRic’s duplex model and the common AGO binding model.
Again we found that chimiRic significantly outperformed TargetScan (Figure
2.3b, p < 1.91e-6, signed rank test) and mirSVR (Figure 2.3b, p < 4.77e-5, signed
rank test) on held-out miRNA seed families in HEK293, with minordifference
in chimiRic’s performance compared to the HEK293-specific model. Similarly,
when predicting the biochemically defined target sites of held-out miRNA
families in CD4 T cells, chimiRic’s duplex model combined with either the T cell
specific or the common AGO binding model outperformed TargetScan (Figure
2.3c, p < 2.38e-7 and p < 2.38e-7, signed rank tests) and mirSVR (Figure 2.3c, p <
2.38e-7 and p < 2.38e-7, signed rank tests).
As an independent validation, we also evaluated chimiRic’s performance
in a third cellular context using two HITS-CLIP data sets in HeLa cells [27,
59]. Again, we found that the common AGO binding model combined with
duplex model had a significant advantage over TargetScan (Figure 2.3d, p <
1.91e-5, signed rank test) and mirSVR (Figure 2.3d, p < 3.29e-3, signed rank test).
Evaluation using auPR50, which favors TargetScan by allowing reduced recall,
still showed a significant performance advantage of the common chimiRic
model over TargetScan and mirSVR in HEK293 and T cells, with a statistical
tie on the HeLa cells. We also evaluated the performance of three additional
methods, MIRZA-G [53], MirTarget [60] and DIANA-microT-CDS [61], all of
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which are trained on AGO CLIP data and provide one a single prediction score
for each miRNA-gene interaction. When we compared the performance on
the same HeLa data set, the common chimiRic model outperformed all three
methods measured by auPR (Figure 2.3e, p < 7.90e-4, p < 1.91e-5 and p < 1.68e-3,
signed rank test), partly due to chimiRic’s better recall. When measured by
auPR50, chimiRic still achieved a statistical tie against these methods, showing
that chimiRic’s top-ranked predictions are at least as accurate as other methods
trained on AGO CLIP data sets.
2.3.4 AGO-binding model learns 3’UTR positional preferences
and RNA-binding motifs associated with miRNA targeting
Previous studies have suggested that 3’UTR miRNA target sites tend to reside
near the stop codons or near the 3’ end of the transcript rather than the
middle of 3’UTRs [26]. We confirmed a positional enrichment of AGO-bound
sites near the stop codons (Figure 2.4a, top) and near the end of the 3’UTR
compared to miRNA seeds with no AGO binding in CD4 T cells across mouse
transcripts. Additionally, for multi-UTR transcripts, we observed an enrichment
of AGO-bound sites in the region upstream of internal 3’ cleavage sites (as
mapped by PolyA-seq) that was absent for the negative site examples (Figure
2.4a, top, p < 2.2e-16, KS test). We also observed an enrichment of positive
site examples ∼200nt downstream of internal cleavage sites, suggesting that
the resolution of the mapped 3’ ends in the mouse atlas is limited and/or that
clusters of nearby 3’ cleavage sites confound the analysis.
To further interpret the sequence features in the AGO binding model,
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we used the positional oligomer importance matrix (POIM) [62] approach to
identify the significant positional k-mers. From the 1-mer POIMs, we observed
not only high AU content flanking the miRNA seed matches in general but
also specific positional signals like m1A and m8/9U, which are consistent
with findings from previous studies [48]. Moreover, the representation
allowed us to go beyond single nucleotide composition, which is the extent
of sequence contextual information used in most previous miRNA target
prediction methods, to explore more complex sequence features.
Previous studies have suggested that various RNA binding proteins (RBPs)
can bind to regions proximal to miRNA target sites in order to enhance
or repress miRNA-mediated regulation [63–65]. Therefore, one potential
explanation for the long positional k-mers that discriminate between AGO
binding sequences and unbound sequences is that they correspond to the motifs
of co-binding RBPs that mediate AGO occupancy. To explore this hypothesis,
we matched the 6-mers from positions with top differential POIM scores to
RNAcompete in vitro affinity data for a compendium of RBPs [66, 67]. By
measuring the enrichment of these k-mers in RNAcompete data across all
RBPs and assessing significance relative to an empirical null model based on
training SVMs on random permutations of the class labels, we found that the
position-specific k-mers in upstream and downstream sequences were indeed
consistent with several known RBP motifs (Figure 2.4b). In the common
AGO-binding model, we identified an AC-rich motif upstream of the seed
match that matched an AGO RNAcompete experiment and has been proposed
to be the miRNA-independent binding signal for Argonaute [67]. Meanwhile,
in the downstream component of the common model, Pumilio was identified as
the most significant RBP motif. It has been previously suggested that Pumilio
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has a role in regulating miRNA site accessibility of specific target genes [64, 65,
68]. Our analysis suggests that Pumilio may play a transcriptome-wide role
in mediating AGO binding. We compared the HEK293 AGO CLIP to PUM2
PAR-CLIP in the same cell type and found that 16.4% of AGO sites in HEK293
overlapped with PUM2 binding sites. Figure 2.4c shows one example of a
miR-17/20/106 target site in the 3’UTR of UBNX2A together with sequence
signals identified by the model. After decomposing the SVM sequence scores
into positional prediction scores, we found that the positions with positive
contribution overlapped exactly with the Pumilio binding motif and Pumilio
CLIP coverage. In contrast, another miR-17/20/106 seed match site in the same
3’UTR was not bound by AGO and lacked significant positional k-mers from
the sequence model.
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Figure 2.4: Interpretation of the AGO-binding model learned from CLIP-seq
data. (A) Positional distribution of AGO binding sites (blue/green) and
unbound sites (grey) within 3’UTRs in CD4 T cell (top) and HEK293 (bottom),
showing enrichment of bound sites near the start of the 3’UTR (left) and
in the region upstream of internal 3’ cleavage sites of multi-UTR transcripts
(right). There is also enrichment of AGO-bound sites ∼200nt downstream of
internal 3’ cleavage sites, suggesting that the resolution of the PolyA-seq peaks
can be limited and/or that clusters of nearby 3’ cleavage sites confound the
analysis. All distances were between the position aligned against nucleotide 2
of the miRNA and the start/end of the corresponding 3’UTR. (B) RBPs with
motifs that match the most discriminative k-mers in the common sequence
model. Positions with the highest differential POIM for 6-mers upstream and
downstream of the miRNA seeds were chosen, and then a signed rank test
was used to assess the enrichment of POIM k-mers in RNAcompete array
probes. False discovery rates (FDRs) were estimated using the empirical p-value
distribution from 1,000 SVMs trained on random permutations of the +/- labels.
Motif logos summarized from the original RNAcompete assays are shown for
the top 5 RBPs as ranked by FDR. (The same RBP symbol may appear multiple
times since in some cases several constructs of the same protein were assayed
by RNAcompete.) (C) An example of co-binding of Pumilio and Argonaute
at miRNA target sites. Two miR-17/20/106 seed matches within the 3’UTR
of UBNX2A are shown, one with AGO2 binding and one without, along with
the coverage profiles of AGO2 and PUM2 CLIP in HEK293. For each site, the
prediction scores from the SVM sequence model are decomposed into positional
scores and displayed. Sequence features near the target site including the
Argonaute motif, Pumilio motif, m1A and m9U are also highlighted.
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2.4 Discussion
We have presented an integrative model for predicting miRNA binding sites
by training on sequencing assays that map biochemical interactions via AGO
cross-linking and miRNA-mRNA ligation. We demonstrated that chimiRic
can detect non-canonical miRNA-mRNA binding modes and significantly
outperforms MIRZA for predicting the interacting miRNA for both canonical
and non-canonical mRNA target sites. Moreover, chimiRic outperforms
TargetScan, a leading target prediction method, for discriminating canonical
seed sites that are bound by AGO from unbound sites. The feature
representation of our AGO binding model exploits recent 3’-end sequencing
data that identifies alternative 3’UTR isoforms and enables analysis of mRNA
sequence signals in the vicinity of the miRNA binding sites, suggesting that
other RBPs may collaborate with AGO to mediate miRNA-mRNA interactions.
ChimiRic directly predicts miRNA targeting by learning from miRNA
binding data, whereas most existing algorithms infer miRNA targets and model
their efficiency using mRNA expression changes in miRNA overexpression
experiments in cell culture [49, 50]. One major issue with methods trained
solely on gene expression changes is that the direct effects of miRNA
regulation are confounded with secondary effects, leading to label noise
in the learning problem. Since the true binding sites that mediate direct
regulation are unknown in this setting, inference of miRNA targets involves
“bootstrapping” from an initial set of assumptions of what constitutes a
viable target. Furthermore, miRNA transfections in cell culture represent a
non-physiological context for miRNA activity and may not accurately reflect
endogenous targeting rules. Finally, miRNA binding can inhibit translational
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efficiency of target mRNAs in addition to or instead of reducing mRNA
abundance [69]. While previous global studies suggest that miRNA-mediated
changes at the mRNA and protein levels are correlated [19, 70], these data
also depend on miRNA overexpression in cell lines. For all these reasons,
it is possible that what we have already exhausted what can be learned
indirectly from mRNA expression changes due to miRNA perturbations—and
from miRNA overexpression experiments in particular—and that new AGO
CLIP and CLASH technologies for mapping direct interactions are required to
advance our understanding of miRNA targeting in cells.
However, recent assays for mapping AGO sites and miRNA-mRNA
interactions are technically difficult and present significant challenges for
computational analysis and training of predictive models. CLASH and
similar protocols that use RNA ligation to capture miRNA-mRNA interactions
currently have very low ligation efficiency (only ∼2% of reads are chimeric)
[30, 31], suggesting that a large number of miRNA-mRNA interactions remain
uncaptured. Some non-canonical interactions recovered by CLASH may be due
to artifacts or biases in the ligation experiments, and one previous study found
that incorporating chimeric reads into MIRZA did not significantly improve
prediction performance [53]. Even in the more mature CLIP assays, data
reproducibility is still limited and strongly affected by technical differences
between various protocols (e.g. PAR-CLIP, HITS-CLIP, iCLIP) that produce
protocol-specific biases [39] and by the potential false positives resulted from
background binding [41]. In our experiments, we only trained on data sets
with multiple biological replicates in order to ensure saturating coverage and
to correctly label the mRNA sites as positive or negative. We further used
a multi-task strategy to absorb dataset-specific differences into task-specific
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models and learn a common model that captures general sequence signals
and positional preferences of AGO binding. Although the extent of miRNA
target context-specificity remains unclear [71, 72], it is still possible that there
are true biological differences in AGO occupancy between cell types. Indeed,
even directed perturbation of a single miRNA-mRNA interaction can lead to
distinct changes in functional responses in different immune cell types [73].
Ultimately, as CLIP-based technologies mature and larger data sets accrue,
the algorithmic approaches we present here may reveal the RNA sequence
elements and trans-acting factors that mediate cell-type specific miRNA-mRNA
interactions.
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CHAPTER 3
THE EFFECT OF CELLULAR CONTEXT ON MIR-155 MEDIATED GENE
REGULATION IN FOUR MAJOR IMMUNE CELL TYPES
Portions of this chapter are soon to be published and were written in
collaboration with Jing-Ping Hsin, Gabriel Loeb, Christina Leslie and Alexander
Rudensky1.
3.1 Introduction
Cell type-specific regulation of gene expression, which is frequently
mediated by commonly expressed sequence-specific transcription factors,
is one of the foundational principles in developmental biology. Like
transcriptional regulators, miRNAs with a proven, non-redundant role in
cellular differentiation or function and their mRNA targets can be found in
multiple cell types. In the immune system, a prime example of such miRNA
is miR-155, whose expression is observed in functionally distinct T cell subsets,
B cells, NK cells, macrophages, and dendritic cells, where it is induced in
an activation or a differentiation stage-specific manner [74, 75]. miR-155 is
also highly expressed in myeloid and lymphoid malignancies, where it plays
an oncogenic role [76, 77]. Our recent study showed that miR-155 mediated
regulation of an inducible target gene, Socs1, has widely differing cell type-
and biological context-dependent functional significance in distinct types of
lymphocytes [73]. Previously, we employed CLIP technology to identify
1As per the Cornell dissertation guidelines, the dissertation can include material that has
been previously published or is soon to be published.
35
miR-155 targets through analyses of miR-155-suffienct and -deficient activated
CD4 T cells [29]. Upon closer examination of the resulting datasets, we came
across of a subset of conserved canonical miR-155 sites in expressed mRNAs
that were not bound or regulated by miR-155 [29]. This finding raised the
possibility that these sites may enable differential regulation of these targets in
developmentally related immune cell types with a shared developmental origin.
However, recent analyses of immortalized human cell lines of different
tissue origin including hepatocellular carcinoma, cervical cancer, and
embryonic kidney cell transfected with hematopoietic and neuronal miRNAs
(miR-155 or miR-124, respectively) showed that the majority of computationally
predicted target mRNAs are repressed in a cellular context independent
manner; a minor subset of differential regulation of a minor subset of
miRNA targets observed in these cells was largely due to an alternative
3’UTR isoform usage with only two target mRNAs potentially regulated
in an ApA-independent manner in miR-155 transfected cells [71]. While
these experiments relied on overexpression of ectopic miRNAs, gene array
and 3’UTR-seq analyses of mRNA expression in six different organs from
miR-22–deficient and –sufficient mice were consistent with these results [71].
It can be argued, however, that differential regulation of mRNA targets
by an endogenously expressed miRNA is more likely to be encountered in
differentiated cell types of common developmental origin in response to a
challenge or a developmental cue. Indeed, both endogenous cellular miRNAs
and miRNAs encoded by Kaposi’s sarcoma-associated herpes virus were found
to regulate the expression of a sizable fraction of targets in distinct B cell
lymphoma cell lines in a context-dependent manner [72]. However, the
contribution of alternative 3’UTR isoform usage to miRNA-mediated regulation
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of gene expression was not considered in this study [72]. Thus, it remains
unknown whether endogenously expressed miRNA are capable of regulation
of commonly expressed target genes solely in a cell context-independent or also
in a cell context-dependent manner.
We sought to address this question through computational and comparative
genome-wide molecular analyses of RISC bound mRNAs, using individual
nucleotide resolution CLIP (iCLIP) [36], their 3’UTR usage (PolyA-Seq) and
miR-155-dependent repression (RNA-Seq) in four key immune cell types –
activated macrophages, dendritic cells, B cells, and CD4 T cells – isolated
from miR-155-sufficient and -deficient mice. The analyses of the resulting
datasets revealed notable cellular context-dependent miR-155 targeting and
regulation of gene expression. While ApA contributed to differential miR-155
binding to some transcripts, in a larger number of cases, identical 3’UTR
isoforms were differentially regulated across cell types. These results
suggest ApA-independent and cellular context-dependent miR-155-mediated
post-transcriptional regulation of gene expression reminiscent of transcriptional
regulation by sequence-specific transcription factors. Furthermore, our
study provides comprehensive comparative maps of miR-155 regulatory RNA
networks as well as global miRNA-mediated AGO binding and genome-wide
3’UTR usage in key activated immune cell types.
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3.2 Methods
3.2.1 Computational processing of iCLIP data
When we processed the iCLIP sequencing data, we first de-multiplexed the
libraries based on the barcodes at 5’ end of the reads, and then preprocessed the
reads using the cutadapt [78] software to remove the adaptor and low-quality
bases. The remaining reads were aligned to the mouse genome (mm9) using
the BWA aligner [79]. Multiple reads aligned to identical coordinates with the
same random 7-mer in the barcode were considered as PCR duplicates and were
merged into a single read to adjust for potential duplication biases. We then
ran our peak-calling algorithm CLIPanalyze (manuscript in preparation) on the
combined read coverage from all samples. The algorithm identified peaks by
convolving the read coverage signal with the second derivative of a Gaussian
filter. The locations where the convolved signal crosses zero correspond to the
rising and falling edges in the original signal and these are used as boundaries
for the peaks. Each peak was annotated with the corresponding gene name
and its location within the gene (i.e. intron, CDS, 5’UTR, 3’UTR). Peaks within
intergenic regions further than 5 kb downstream and 1 kb upstream from
annotated genes were excluded from subsequent analysis. The peaks were then
quantified by counting the number of uniquely aligned reads mapped within
peak boundaries in each library. To filter the low-abundance peaks, we first
restricted to peaks with supporting reads in at least 4 out of 8 samples in at least
one cell type. For each individual cell type, we did a second round of filtering
and only kept the peaks with total read counts within the top 10 percentile for
the differential analysis. We then fit the read counts from those peaks using
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negative binomial generalized linear models [80] with TMM normalization [81],
and tested the significance of the difference in read counts between wild type
and miR-155 KO samples with likelihood ratio test.
3.2.2 Computational processing of gene expression data
We preprocessed the paired-end reads using cutadapt to remove the adaptors
and low-quality bases. The processed reads were then aligned to the mouse
genome (mm9) using the STAR aligner [82]. To account for the variation in
3’UTR usage, we only counted the reads aligned to CDS for coding genes. The
read counts per gene were further normalized as fragments per kilobase per
million (FPKM) to represent the mRNA abundance.
Differential gene expression analysis was performed for microarray datasets
of miR-142a-sufficient and -deficient B cells (GSE61919) [83] and bone marrow
derived miR-142a-sufficient and -deficient dendritic cells (GSE42325) [84] using
limma [85]. To estimate gene regulation mediated by miR-27a, differential gene
expression analysis was performed on a RNA-Seq dataset of wild type and
miR-27a-overexpressed CD4 T cells (GSE75909) [86].
3.2.3 Computational processing of PolyA-Seq data
The preprocessing, alignment, peak calling and quantification steps for the
PolyA-Seq libraries were performed in the same way as the iCLIP libraries.
Internally primed peaks were removed in the same approach as previously
described [58]. The read counts were then fitted using the DEXSeq model [87] in
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order to identify the differential usage of 3’UTR isoforms between conditions.
3.3 Results
3.3.1 Differential AGO2 iCLIP reveals context specificity of
miR-155 targeting in activated immune cells
To comprehensively characterize the miR-155 regulatory network, we used
iCLIP [36] to precisely map the miR-155 target sites, RNA-Seq to measure the
repression levels of target genes, and PolyA-Seq [47] to map and quantify 3’
UTR isoforms in B cells, dendritic cells, macrophages and CD4 T cells extracted
from both wild type and miR-155 KO mice (Figure 3.1a). As previously
reported [88–91], miR-155 expression was significantly increased upon immune
activation in all four cell types, with peak induction levels observed at 24 h
and extending to 48 h. We used Argonaute 2 antibody to immunoprecipitate
RISC-bound RNA from cells activated for 48 h and generated iCLIP libraries
from the isolated RNA captured both the microRNAs and their mRNA target
sequences. Cellular abundances of mature microRNAs were estimated from
reads aligned to the corresponding loci in primary microRNA sequences, which
confirmed that miR-155 was the only major microRNA with significant change
in expression between WT and miR-155 KO cells. By applying our CLIP
processing pipeline CLIPanalyze (manuscript in preparation) to the genomic
alignments after removal of potential PCR duplicates, we first identified
peak regions in the combined read coverage track (WT and KO replicates)
from all cell types. We then modeled the read counts within peaks using
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negative binomial generalized linear models [80] with TMM normalization [81]
and determined the miR-155 dependent sites as peaks with (1) overlapping
transcript annotation from RefSeq; (2) complementary match to miR-155 2-7
6-mer seed sequence; and (3) significantly higher read counts in wild type
samples than miR-155 knockout samples (Benjamini-Hochberg adjusted p <
0.025). In total, 1,200 such sites were found in 999 genes across four cell types,
including 796 (66.3 %) in 3’ UTRs, 386 (32.2 %) in CDS (coding sequence), and
18 (1.5 %) in 5’ UTRs. In particular, among these initial 1,200 sites, only 111 (9.25
%) were found to be miR-155 dependent in all four cell types, while the rest of
the targets exhibited varying degrees of context specificity.
3.3.2 Differences in target mRNA and miR-155 abundance do
not account for all miR-155 targeting specificity
One obvious explanation for the observed context specificity could have been
that some of the cell-type specific miR-155 target genes were not expressed or
were expressed at very low levels in the other cell types. Indeed, when a gene
contains a miR-155 target specific to one cell type, its mRNA expression in
that cell type also tended to be higher than in those where the target did not
show differential iCLIP signal. When we restricted the comparison between cell
types to the co-expressed genes (RNA-Seq FPKM > 1 in all cells and < 16-fold
difference between any two cell types), 931 target sites in 778 co-expressed
genes remained and most of the context specificity was preserved (Figure 3.1b
and 3.1c). Therefore, the base mRNA expression differences alone cannot fully
account for the observed cell context-specific targeting.
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The difference in miR-155 abundance after immune stimulation across cell
types can also partially explain the cell context specificity of miR-155 targeting
– the largest number of cell-type specific target sites were found in dendritic
cells, where miR-155 expression was also the highest (Figure 3.1b). The number
of miR-155 dependent sites identified in each cell type is consistent with relative
miR-155 expression (Figure 3.1c), suggesting that some context-specific sites
may have weaker affinity to miR-155 and, therefore, can only be regulated
in the presence of higher miR-155 levels or other cellular factors. Indeed,
when we categorized the miR-155 targets by the number of cell types that they
are present in, the proportion of sites with only 6-mer complementarity was
significantly lower for target sites present in more cell types than those present
in fewer cell types (Fisher’s exact test p < 2.57e-10), and the proportion of sites
with 8mer complementarity significantly higher (Fisher’s exact test p < 1.79e-9;
Figure 3.1d). Similar to previous observations [72], the sequences surrounding
shared sites also showed significantly higher evolutionary conservation than
the sequences around cell-type specific sites (Figure 3.1e). Nevertheless,
large numbers of context-specific targets are still present in cell types with
lower miR-155 expression, suggesting that other cellular factors or potentially
alternative cleavage and polyadenylation (ApA) play a role in cell-type specific
targeting.
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Figure 3.1: miR-155 mediated Argonaute binding occurs at distinct sites in
four immune cell types. (A) Examples of universally bound and differentially
bound miR-155 sites across all 4 cell types. Normalized read coverage tracks
of iCLIP, RNA-Seq and PolyA-Seq libraries are shown for each cell type, in
which dark and light colors correspond to the wild type (WT) and miR-155
knockout (KO) samples. iCLIP peaks are defined by the grey shade in the
background, while asterisks designate the cell types with significant (FDR <
2.5%) difference between WT and KO coverage. (B) Summary of miR-155
dependent sites in co-expressed genes, including 3’UTR, CDS, and 5’UTR sites,
identified by differential iCLIP. Each row in the heatmap represents 250 bp
around a miR-155 6-mer seed match, whereas the colors represent the log
ratios between normalized WT and KO iCLIP coverage per base. Heatmap for
RNA expression (WT RNA-Seq log10 FPKM, normalized by row) of the same
genes containing the miR-155 sites is shown side-by-side. Sites are categorized
according to their binding specificity across 4 cell types, while the order within
each category are determined by hierarchical clustering of RNA-Seq FPKM
values for corresponding genes. (C) Venn diagram of miR-155 dependent iCLIP
sites in co-expressed genes. (D) Seed type composition of miR-155 dependent
sites in co-expressed genes. (E) Average base-wise phastCons scores (for
multiple genome alignments between mouse and other 39 placental mammals)
of miR-155 dependent sites in co-expressed genes.
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3.3.3 miR-155 targeting is unlikely to be influenced by
endogenous RNA competition
The “competitive endogenous RNA (ceRNA)” hypothesis [92] proposes that
transcripts with common microRNA target sites compete with each other for
regulation, which may explain the biological function of some long non-coding
RNAs. There has been growing experimental evidence that certain long
non-coding RNAs [93] and circular RNAs [94, 95] contain large numbers of
microRNA target sites and may function as microRNA “sponges”, particularly
in neurons. However, when we examined miR-155 target sites in mRNA along
with ones within intronic regions and non-coding RNAs, we found the vast
majority of coding and non-coding RNAs only contained one or two miR-155
target sites in all four cell types, with the maximum of six sites found only in
single gene, Picalm. As circular RNAs are generally formed by back-splicing of
consecutive exons [96], we therefore find little evidence of circular RNAs that
“sponge” miR-155 in these four immune cell types.
We also attempted to estimate the fraction of miR-155/AGO complex bound
by a given transcript in each cell. Assuming that iCLIP counts are a reasonable
proxy for miR-155/AGO binding, we estimate that the most bound transcript
in a given cell binds ∼3-10% of the transcript bound complex. This suggests that
these rare already highly expressed transcripts would need to be dramatically
up-regulated to significantly affect overall miR-155 binding within the cell.
Interestingly, the most bound targets are different for each cell type, even
between these closely related immune cells. Among the predominant target
miR-155 genes in dendritic cells was Cd274, encoding the inhibitory receptor
ligand PD-L1, and in macrophages Msr1, encoding macrophage scavenger
45
receptor 1.
0.00
0.25
0.50
0.75
1.00
−0.5 0.0 0.5 1.0
RNA−Seq log2(ko/wt)
All genes (10016)
6mer (2144)
7mer−A1/m8 (1384)
8mer (335)
Targetscan (196)
iCLIP 6mer (196)
a
0.00
0.25
0.50
0.75
1.00
−0.5 0.0 0.5 1.0
CD
F
All genes (10474)
6mer (2245)
8mer (349)
Targetscan (503)
iCLIP 6mer (503)
Dendritic cell
RNA−Seq log2(ko/wt)
0.00
0.25
0.50
0.75
1.00
−0.5 0.0 0.5 1.0
RNA−Seq log2(ko/wt)
CD
F All genes (9819)
6mer (2103)
7mer−A1/m8 (1362)
8mer (324)
Targetscan (264)
iCLIP 6mer (264)
7mer−A1/m8 (1453)
B cell
CD
F
CD4 T cell
0.00
0.25
0.50
0.75
1.00
−0.5 0.0 0.5 1.0
RNA−Seq log2(ko/wt)
CD
F
All genes (10474)
6mer (2201)
7mer−A1/m8 (1421)
8mer (335)
Targetscan (306)
iCLIP 6mer (306)
Macrophage
p < 5.38e-3
(vs. Targetscan)
p < 2.98e-3
(vs. 8mer)
p < 1.61e-8
(vs. Targetscan)
p < 2.04e-2
(vs. 8mer)
p < 3.15e-3
(vs. Targetscan)
p < 1.92e-3
(vs. 8mer)
p < 3.50e-6
(vs. Targetscan)
p < 3.17e-2
(vs. 8mer)
b
c d
Figure 3.2: miR-155 represses distinct sets of genes in four immune cell types.
In dendritic cells (A), B cells (B), CD4 T cells (C) and macrophages (D), the
distribution of gene-level RNA-Seq expression changes between miR-155 KO
and WT cells is shown in the form of cumulative distribution functions (CDFs)
in different sets of genes. Gene sets include all expressed genes, genes with 3’
UTR miR-155 6-mer / 7mer-A1 / 7mer-m8 / 8-mer seed matches and genes
containing 3’ UTR miR-155 dependent iCLIP sites with 6-mer seed matches
(FDR < 2.5%). Predicted miR-155 target genes with top context++ scores
from Targetscan 7.0 (same number as the miR-155 target genes identified by
differential iCLIP) are also shown.
3.3.4 miR-155 mediated gene regulation is consistent with the
context specificity of iCLIP-defined targets
Next, we analyzed the extent of regulation induced by miR-155 dependent
targets identified by differential iCLIP. We used mRNA expression changes
between wild type and miR-155 knockout cells to estimate the extent of miR-155
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regulation per gene. Consistent with previous studies [97], the significance
of miR-155 dependent iCLIP sites in 3’ UTRs correlated with the extent of
regulation of corresponding genes, which was not the case for CDS sites.
Therefore, for further analyses of the effect of miR-155 on gene regulation we
only considered miR-155 targets in 3’ UTRs.
In all four immune cell types, we first examined the distribution of
mRNA expression changes of potential target genes defined by miR-155 seed
matches in the 3’ UTRs. Consistent with well-known microRNA targeting
principles, the extent of miR-155 regulation increased with higher 3’UTR seed
complementarity, from 6-mer to 7-mer-A1/m8 to 8-mer [26]. Still, genes with
miR-155 dependent iCLIP sites in the 3’UTRs displayed significantly stronger
regulation even when compared to the most potent predicted target genes
with 8-mer seed matches in 3’ UTRs (Figure 3.2). We also compared the
iCLIP-defined target genes to same number of genes containing sites with
top context++ scores from Targetscan 7.0 [49]. While the extent of regulation
in the top ∼10% of the distribution was similar for both sets of genes,
the iCLIP-defined target genes overall show significantly stronger regulation
compared to Targetscan predictions (Figure 3.2). These results again suggest
that miR-155 mediated gene regulation across different cellular contexts is
more accurately captured by differential iCLIP assays than cell-type agnostic
sequence-based predictions.
We have previously reported that up to 40% of miR-155 targets identified by
differential AGO2 HITS-CLIP in CD4 T cells are non-canonical [29], i.e. without
complementary match to miR-155 6-mer seed. More recent studies by other
groups using CLIP-based assays with RNA ligation [30, 31, 43, 44] to recover
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miRNA-target interactions have also suggested widespread non-canonical
targeting with 3’ end complementarity. In line with previous reports, we found
non-canonical sites consisted of about 25%-45% of identified AGO2-bound
miR-155 sites in the four immune cell types. The majority of non-canonical sites
were bound in only one cell type, which was consistent with the observation
of canonical seed type composition. Similarly, when we compared the average
iCLIP read coverage around the canonical and non-canonical miR-155 sites, we
found that the difference between wild-type and miR-155-deficient libraries was
much smaller in non-canonical sites, suggesting that the non-canonical sites
have weaker affinity to RISC binding. We found multiple genes significantly
repressed by miR-155 with only non-canonical target sites in 3’ UTR, albeit
the regulation of non-canonical targets was significantly weaker overall than
canonical targets even with the most stringent FDR cutoff.
To further dissect the cell-context specificity of miR-155 regulation, we
performed pairwise comparisons across the four immune cell types to assess the
extent of regulation of common and cell-type specific miR-155 targets (Figure
3.3). In each immune cell type, miR-155 target genes identified by differential
iCLIP always displayed significantly stronger regulation than those specific to
other cell types, with a few exceptions involving B and CD4 T cells, where
fewer cell-type specific targets and generally weaker regulation were observed.
Notably, cell-type specific target genes displayed significantly less pronounced
regulation compared to common target genes, consistent with the weaker seed
complementarity and lower sequence conservation associated with cell-type
specific target sites (Figure 3.1d and 3.1e).
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Figure 3.3: Context-specific miR-155 targeting leads to differences in gene
regulation between cell types. For all six pairwise comparisons across four
immune cells, de-repression of genes containing common (solid lines) and
cell-type specific (dotted lines) 3’ UTR miR-155 dependent iCLIP sites is shown
in the form of CDFs. Genes with 3’ UTR miR-155 seed matches are also shown as
reference. Only co-expressed genes (WT RNA-Seq FPKM > 1 and difference < 16
fold) are included in each pairwise comparison. In each plot, two p-values from
one-sided KS tests are shown. First one corresponds to the comparison between
all miR-155 target genes identified in this cell type and genes only targeted in
the other cell, while the second one corresponds to the comparison between the
common target genes and target genes specific to this cell type.
3.3.5 Alternative polyadenylation has limited contribution to
cell-type specific miR-155 targeting
Another potential explanation for the observed cell type-dependent regulation
of gene expression by miR-155 is alternative polyadenylation. Previous studies
[98, 99] have shown that multi-UTR genes increase the usage of shorter isoforms
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Figure 3.4: PolyA-Seq captures change in 3’ UTR isoform usage during CD4
T cell activation. (A) Two examples of 3’ UTRs with significant (FDR <
5%) isoform usage changes during CD4 T cells activation. Tracks represent
normalized PolyA-Seq read coverage at 0h, 24h and 48h after activation. (B)
The changes in 3’ UTR isoform usage for 3’ UTRs with two major isoforms
at 48 h after CD4 T cell activation. The ones undergoing significant usage
changes were highlighted. (C) Same as (B), but highlighting the two-isoform
3’UTRs containing target sites of miR-155. The 3’UTRs containing proximal
(solid shapes) and distal (hollow shapes) miR-155 target sites were marked
separately, as well as the corresponding numbers.
in activated immune cells, specifically T lymphocytes, simultaneously with
the increase in miR-155 expression, which has been suggested by some as a
potential mechanism to evade miRNA-mediated regulation. We performed
PolyA-Seq in naı¨ve CD4 T cells as well as their activated counterparts after
in vitro stimulation with CD3 and CD28 antibodies for 24h and 48h (Figure
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3.4a). Although differential analysis [87] indeed revealed widespread changes
in 3’UTR isoform usage with a significant shift towards shorter isoforms in
activated cells both at 48h (Figure 3.4b), markedly increased usage of longer
isoforms upon activation was also observed for a sizable group of transcripts
(∼40%). A focused analysis of the two-isoform 3’UTRs targeted by miR-155
did not suggest preferential shortening of transcripts that contained a miR-155
binding site in the long isoform (Figure 3.4c). Changes in 3’UTR length thus
did not appear to significantly relieve miR-155 mediated targeting upon T cell
activation.
To investigate whether alternative polyadenylation contributed to cell-type
specific targeting we performed PolyA-Seq in all four immune cell types. The
PolyA-Seq FPM was well correlated with RNA-Seq FPKM for single-UTR genes,
suggesting that PolyA-Seq is capable of quantifying 3’UTR isoform expression
levels. Differential analysis [87] in all four cell types showed that 2,703 out
of 3,460 co-expressed multi-UTR genes displayed some extent of alternative
polyadenylation (Figure 3.5a). miR-155 targets were significantly enriched in
differentially used multi-UTR genes compared to the other genes (Fisher’s
exact test p < 2.2e-16, Figure 3.5b). Since PolyA-Seq libraries were generated
for both wild type and miR-155 KO cells, the data also allowed us to assess
miR-155 regulation at the level of 3’UTR isoforms. In agreement with previous
observations [26], regulation of a 3’UTR isoform by a given miR-155 target
site negatively correlated with its distance from the 3’UTR end, suggesting
the potential of ApA as a mechanism for context-specific miR-155 regulation.
Indeed, in multi-isoform 3’UTRs, we observed that the extent of gene-level
miR-155 regulation generally increases with higher usage of ApA isoforms
containing miR-155 target sites in individual cell types as previously reported
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Figure 3.5: The role of alternative polyadenylation in cellular context
dependent regulation of gene expression by miR-155. (A) A heatmap showing
the usage changes in multi-isoform 3’UTRs across all four cell-types. The
usage index (UI) represents the usage of the shorter isoform for two-isoform
3’UTRs, while for 3’UTRs with more isoforms it corresponds to the usage
of the one shorter isoform with the most significant usage change. (B)
Composition of 3’UTRs with single isoform, multiple isoforms with and
without context-specific usage, divided into two categories depending on
miR-155 targeting. (C) iCLIP, RNA-Seq and PolyA-Seq read coverage tracks
in Rbm33 3’UTR, an example of the co-occurrence of differential ApA and
context-specific miR-155 targeting between dendritic cell and CD4 T cell. (D)
Venn diagram shows the shared and context-specific 3’UTR miR-155 target
genes between dendritic cell and B cell, before and after removing genes with
differential ApA usage in multi-isoform 3’UTRs.
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[71]. We also observed examples of co-occurrence of ApA and context-specific
miR-155 binding through pairwise comparison between cell types (Figure 3.5c).
However, in most cases, the change in isoform usage between cell types was
less than 10%, while overall expression changes of miR-155 and target mRNAs
had a much larger dynamic range. Therefore, the majority of the observed
context-specific targeting cannot be attributed to alternative polyadenylation
(Figure 3.5d).
3.3.6 Ago iCLIP characterizes functional target sites of other
miRNAs
Our Ago iCLIP data also allowed characterization of target sites for other
miRNAs expressed in the four immune cells. The latter relied on computational
seed sequence analysis within iCLIP peaks in the absence of a genetic control,
i.e. iCLIP and RNA-seq analysis of corresponding miRNA-deficient cells.
When we ranked iCLIP peaks containing miR-155 6-mer seed matches by the
normalized read counts in wild-type libraries, ∼75%-95% in the top 10% of
peaks overlapped with miR-155 dependent sites defined by differential iCLIP.
We therefore reasoned that stringent read count cutoffs could yield reliable sets
of targets for miRNAs other than miR-155. Using the wild-type libraries, we
defined the top target sites for miR-142a-3p and miR-27a-3p, which both play
key regulatory roles in immunity [83, 84, 86] and were highly expressed in the
four immune cells. When we used publicly available gene expression data with
perturbed miR-142a [83, 84] and miR-27a [86] expression in mouse immune
cells, we found that similar to miR-155, the target genes defined by 3’UTR
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iCLIP sites with top read counts in wild-type libraries showed significantly
stronger repression than cell-type agnostic sequence-based predictions (Figure
3.6, one-sided KS test), which suggests that they indeed defined an accurate set
of top miRNA targets in the respective cellular context.
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Figure 3.6: Top iCLIP target sites of other miRNAs induce significant gene
repression. mRNA expression changes in B cells (A) and dendritic cells (B)
with miR-142a KO and in CD4 T cells with miR-27a overexpression (C) are
shown as CDFs for different gene sets. Gene sets consist of all expressed genes,
genes with 3’UTR seed matches (6mer, 7mer-A1, 7mer-m8, and 8mer), and
genes containing 3’UTR iCLIP sites with 6mer seed matches and most reads in
wild-type libraries. Predicted miRNA target genes with top context++ scores
from Targetscan 7.0 (same number as the target genes defined by wild-type
iCLIP) are also shown.
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CHAPTER 4
DISCUSSIONS
4.1 Computational miRNA target prediction
Computational miRNA target prediction methods share the same issue that it
is relatively easy to predict miRNA target sites with the highest affinity, but
the accuracy of prediction rapidly drops when it comes to weaker targets. A
recent study has also suggested that a large proportion of predictions made by
miRNA target prediction methods are likely false positives [100]. As shown by
our study on miRNA context specificity, the variations in miRNA abundance
have a significant impact on the regulation of target sites with weaker affinity
to miRNAs. Therefore, one potential solution to this issue is taking the miRNA
expression levels into account when predicting the target sites in a specific cell
type.
Our original chimiRic model was partially restricted by the limited number
of high-quality AGO CLIP and CLASH data sets available. Since the
publication, more ligation-based data sets have been generated [43, 44], and
we have now recognized the importance of control libraries in correcting the
intrinsic biases of CLIP data [37, 41]. Besides better data quality, miRNA target
prediction algorithms may also benefit from novel machine learning methods.
Algorithms based on deep neural network have proved to be powerful tools
for modeling genomic data [101, 102], and recently they have also been applied
to predicting miRNA target sites based on AGO CLIP data [103]. In addition,
more powerful machine learning algorithms can potentially help us revisit the
rich miRNA perturbation expression data sets accumulated over the years [104]
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and recover features of miRNA target sites that were previously neglected in
individual studies.
4.2 Context specificity of miRNA regulation
In our study on miR-155 regulation in immune cells, we observed significant
context specificity of miRNA regulation, contradicting the results of previous
perturbation assays in cell lines and in whole tissues [71]. A possible
explanation is that the cell lines used in previous study are not developmentally
related, and that bulk gene expression in whole tissues may limit the discovery
of more subtle differences in gene regulation. We only observed a small number
of context-specific miR-155 targets potentially affected by ApA, although in
theory ApA can play a more significant role in tissues where ApA events are
more prevalent, like in brain [58].
Limited by the relatively small number of context-specific miR-155 targets
in our data, we did not fully explore other ApA-independent mechanisms
of miRNA context specificity. We hypothesize that regulation by RBPs
differentially expressed between cell types can play a significant role. More
than 1,500 RBPs have been identified in human [105], and individual studies
have identified multiple RBPs as either enhancers [64, 106] or inhibitors [63] of
miRNA regulation. There has been attempts at systematic characterization of
RBPs’ impact on miRNA regulation [107], but they were largely limited by the
lack of direct measurement of RBP binding. A large number of high-throughput
data sets of RBP binding sites have been generated in recent years, which
may help resolve this issue. In particular, the ENCODE eCLIP experiments
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have characterized the binding regions of 126 RBPs in human cells [108].
Comprehensive analysis of RBP co-binding profiles would greatly enhance our
understanding of how RBPs modulate miRNA regulation and how they can
contribute to cell-type specific miRNA targeting.
mRNA modifications, such as adenosine methylation (N6-methyladenosine,
m6A), can be another potential factor contributing to context-specific miRNA
regulation. It has been previously observed that >70% of m6A residues are
present in the last exons of transcripts [109], which significantly overlap with
miRNA target sites. A different modification (N6,2’-O-dimethyladenosine,
m6Am) at the first encoded nucleotide adjacent to the 5’ cap has also been
suggested to stabilize mRNAs by preventing miRNA-mediated degradation
[110]. Comprehensive mapping of transcriptome-wide RNA modifications
can help us better understand the various mechanisms involved in miRNA
regulation.
4.3 Technical advances in the detection of RBP binding sites
Continuous efforts have been made in order to improve the efficiency of
CLIP protocols. The “on beads” PAR-CLIP protocol performs all RNA
adapter ligation steps while RNA fragment is still cross-linked to the
RBP, reducing the library preparation time by three days compared to the
original PAR-CLIP workflow [111]. The infrared-CLIP (irCLIP) protocol [112]
uses an infrared-dye-conjugated and biotinylated RNA ligation adapter to
eliminate the need for radioisotopes to visualize protein-RNA complexes.
In combination with improved RNA digestion, purification and reverse
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transcription procedures, this protocol greatly increases the efficiency of CLIP
library preparation and enables direction of protein-RNA interactions using far
fewer cells.
One intrinsic limitation of CLIP protocols is that the stringency of washing
to remove non-specific protein interactions is restricted by the strength of
protein-antibody interactions. Therefore, an additional protein gel purification
step is necessary, which further reduces the efficiency of CLIP protocol [45].
Moreover, specific antibodies may not be available for certain RBPs. Instead
of relying on immunoprecipitation, an alternative strategy is to use CRISPR
to insert protein purification tags (such as HIS, Bio/BirA, or TAP-TAG) next
to the genomic loci of RBPs, forming fusion proteins that can be captured
by stronger covalent interactions and allow harsher washing to remove
non-specific interactions. Notably, the recently developed Halo Tag has highly
specific affinity to the HaloLink resin for protein capture [113], therefore offering
great potential for further improvement of protein capture specificity. For these
assays, preliminary experiments would be necessary to ensure that the added
tags do not disrupt the in vivo binding affinity and biological functions of the
original RBPs.
Furthermore, researchers are also exploring methods that does not involve
protein pulldown and crosslinking. One such method, TRIBE, fuses the
deaminase domain of a RNA-editing enzyme, ADAR, to the RBP of interest
[114, 115]. The fusion protein introduces A-to-I RNA editing near RBP binding
sites, which can be detected by RNA sequencing. Since RNA-Seq requires much
fewer cells than CLIP, TRIBE enables characterization of differences in RBP
regulation between small populations of cell subtypes. On the other hand, the
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potential bias in the selection and efficiency of editing sites needs to be carefully
evaluated, since current results suggest that the ADAR deaminase domain may
retain some of binding preference of the original enzyme [114, 115].
4.4 Unsolved questions
Multiple important questions regarding the physiological consequences of
miRNA regulation remain unsolved. It is still unclear how miRNAs can have
massive phenotypes when the majority of miRNA targets are only mildly
repressed [19, 70]. Theoretical and experimental analyses have suggested
that miRNA regulation can reduce the variations in mRNA and protein
abundances [116], which may play more important regulatory roles than
simple repression of target gene expression. The competitive endogenous
RNA (ceRNA) hypothesis [92] proposes that transcripts with common miRNA
target sites compete with each other for regulation, which provides another
attractive theory for the mechanism of miRNA regulation. It has been found
that certain long non-coding RNAs [93] and circular RNAs [94, 95] contain
large numbers of miRNA target sites and may be the miRNA “sponges” that
the ceRNA hypothesis proposes. On the other hand, quantitative modeling
and measurements showed that the majority of active miRNAs are probably
not susceptible to ceRNA competition [42, 117]. To date, the ceRNA hypothesis
remains controversial because of these conflicting observations [118]. Overall,
25 years after its discovery, miRNA regulation continues to provide challenges
and opportunities to both experimental and computational biologists.
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APPENDIX A
THE CLIPANALYZE DATA PROCESSING PIPELINE
Portions of this chapter first appeared in Park et al. [119] and were written in
collaboration with Sun-Mi Park, Christina Leslie and Michael Kharas 1.
A.1 Introduction
Investigations in RBP biology are increasingly dependent on CLIP and related
high-throughput sequencing protocols. On the other hand, due to various
biases and noises present in CLIP libraries, careful computational analysis is
necessary for correct interpretation of CLIP data. Several CLIP data analysis
pipelines have been developed before, but to date none of them have been
widely adapted by the research community, since most of them were limited
to certain CLIP protocol variants. We have implemented a software pipeline
that performs standard CLIP data processing procedures including peak
identification, annotation and quantification in a highly efficient manner. In
addition, our pipeline accounts for biases in CLIP libraries that come from two
major sources, PCR duplication and non-specific protein-RNA interactions. We
release our pipeline as a R package CLIPanalyze, and the source code is publicly
available at https://bitbucket.org/leslielab/clipanalyze.
1As per the Cornell dissertation guidelines, the dissertation can include material that has
been previously published or is soon to be published.
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A.2 Methods
A.2.1 Pre-processing and alignment
To adjust the potential biases generated by uneven PCR amplification, it has
become a common practice of various CLIP protocols to include a randomized
barcode sequence in the adapter or reverse transcription primer [27, 36, 37]. Our
pipeline stripped the random barcodes from read sequences and attached them
to read names in FASTQ files. After read alignment, multiple reads mapped
to identical coordinates with the same random barcode were considered as PCR
duplicates and were merged into a single read to adjust for potential duplication
biases. In case that the CLIP libraries were constructed without random
barcodes [42, 120], our pipeline also supported only using the alignment
coordinates to remove PCR duplicates.
A.2.2 Peak calling
Our peak calling approach was inspired by the edge detection algorithm in
computer vision, where sharp changes in brightness in an image are detected
as edges of an object by computing the rate of change of the intensity gradient.
To identify peaks, we first combined the reads from all of the CLIP libraries
together. We then constructed a 1D signal profile of read coverage, K[x], which
contains cumulative read counts for each position x from all CLIP libraries.
To simultaneously smooth and identify edges in the signal, this profile was
convolved with a kernel derived from the second derivative of a Gaussian (g′′D),
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with a mean of 0, standard deviation of 1, and customized bandwidth:
g′′D[x] =
( x2
σ4
− 1
σ2
)
exp
(
− x
2
2σ2
)
The customized bandwidth parameter allows adaptive peak calling across
different CLIP data sets, since the typical peak sizes in CLIP libraries can be
highly variable depending on the RBPs and experimental conditions [37]. The
edges in the original signal are located at the zero-crossings of the convolved
signal:
(K × g′′D) [x] =
m/2∑
n=−m/2
K[x + n] × g′′D[n]
The zero-crossings of the second derivative that switch from positive to negative
indicate the edges that start a peak, and the points that switch from negative to
positive identify the ends of each peak.
A.2.3 Peak annotation and quantification
Each CLIP peak was annotated according to the RefSeq gene annotation. Genes
with multiple transcripts were reduced to a unified gene model, which is the
union of all annotated exons. To account for possible gene structure variations
that were not annotated, for each gene we extended the first exon 1 kb upstream
and the last exon 5 kb downstream. Using these models, each CLIP peaks was
then annotated to a specific genomic region within the gene (CDS, intron, 5’
UTR, and 3’ UTR) that the peak overlapped with. If a genomic region can be
assigned to multiple categories, we assigned it to one of them with a customized
priority order. The default order is: 3’ UTR, CDS, 5’ UTR, and intron. Peaks
that mapped to multiple genomic regions were assigned to the region with
maximum overlap. Once the peaks were identified and annotated, we then
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quantified peaks in each experiment by counting the number of reads from each
experiment that overlapped with each peak. Reads that overlapped more than
one peak were assigned to the peak with which it had maximum overlap.
A.2.4 Normalization against control libraries
Since non-specific binding events are prevalent in CLIP [37, 41], it is highly
recommended to normalize the CLIP-identified peaks against control libraries.
For each peak, we used negative binomial generalized linear model [80, 121]
to fit the difference in read counts between CLIP and control libraries. This
approach can be easily adapted to more sophisticated experimental designs
with additional factors. Considering the fact that the CLIP libraries intrinsically
have more reads in peaks than the control libraries, we estimated the library
sizes using the number of reads outside of CLIP peaks per gene instead of using
the number of reads within peaks. The p-values from differential tests can then
be used to represent the confidence of each peak.
A.3 Example: Computational analysis of MSI2 CLIP-seq in
K562 cells
Earlier versions of CLIPanalyze pipeline has been applied to CLIP-seq data sets
generated by multiple studies [29, 119, 122]. Here we describe details of the
computational analysis performed for MSI2 HITS-CLIP [119]:
The Musashi (MSI) family of RNA-binding proteins, including MSI1 and
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MSI2, contribute to the control of symmetric and asymmetric stem cell division,
regulate stem cell function, and play a role in cell fate determination [123]. MSI
proteins are thought to function by binding to the 3’UTRs of target mRNAs
at a consensus sequence and then blocking translation by hindering access
of the poly-A–binding protein to the elongation initiation complex [124]. In
particular, MSI2 is an important modulator of proliferation and differentiation
in both normal HSCs and in myeloid malignancies. Although MSI2 is most
highly expressed in the primitive hematopoietic compartment, and MSI2
overexpression drives quiescent HSCs out of G0 and into cycle [125], it remains
unclear whether and how MSI2 affects HSC self-renewal and commitment
under homeostatic conditions. Furthermore, the critical RNA-binding targets of
MSI2 in hematopoietic cells that regulate self-renewal and lineage commitment
remain to be uncovered.
In order to globally capture the direct RNA targets of MSI2 in hematopoietic
cells, we performed HITS-CLIP in K562, a human chronic myeloid leukemia
cell line. We overexpressed FLAG-tagged MSI2 protein in parallel to a control
vector lacking the MSI2 cDNA in K562 cells, and HITS-CLIP libraries were
generated using anti-FLAG M2 antibody. Since FLAG-tagged MSI2 protein
was not expressed in control cells, HITS-CLIP reads from the control sample
were generated by non-specific binding of the antibody and other sources of
background noise. A fraction of reads in samples with overexpressed MSI2 also
came from these noise sources [27]. Therefore, we were interested in identifying
HITS-CLIP peaks with significantly higher read counts in MSI2-overexpressing
cells relative to control, as they are likely to be the real MSI2-binding sites.
However, as mRNA expression levels may change between different conditions,
differential read counts at a site can be caused either by a change in transcript
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abundance or by differential MSI2 binding. To identify real differential binding
events, it is necessary to integrate gene expression data into the analysis.
We jointly modeled read count data from HITS-CLIP and RNA-Seq with a
generalized linear model. We represented the read count from a window
containing peak i in sample j as Ki j. Here, the read count represents either
HITS-CLIP reads or RNA-Seq reads in the window, depending on sample j.
It is assumed that Ki j follows a negative binomial distribution, which has been
widely used in modeling read count data [80].
For each peak i, the expected value of Ki j (denoted by µi j), is fit via a
logarithmic link by the following model:
logµi j = β0i + β
CLIP
i X
CLIP
j + β
OE
i X
OE
j + β
CLIP:OE
i X
CLIP:OE
j + logN˜ j
Here N˜ j represented scaled library size of sample j, which was the total
read count in sample j scaled by the weighted trimmed mean of log expression
ratios. It was included as a normalization factor. After normalization, the
logarithm of this variable is decomposed into four factors, where the regression
coefficients have the following interpretation: β0i represents the baseline log
expression level measured by the window at peak i; βCLIPi represents the baseline
log read count ratio of CLIP reads to RNA-Seq reads at peak i; βOEi represents
the effect of MSI2 overexpression on read counts caused by mRNA expression
changes. Finally, the interaction term βCLIP:OEi represents differential MSI2
binding caused by overexpression; this coefficient will be non-zero if there is
differential binding even after controlling for differential mRNA expression.
Factors XCLIPj , X
OE
j and X
CLIP:OE
j equal 1 or 0, depending on the condition and
library type of sample j. To test whether the interaction term is 0, we fit data
to both the full model and a reduced model without the interaction term. Then
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the deviances of two models were used to conduct a likelihood ratio test. If
there is no true differential binding effect, the difference in deviances between
the nested models should be small compared with a χ2 distribution with one
degree of freedom. In this way, we were able to characterize the significance
of differential binding with a p-value. Finally, we defined MSI2-binding sites
as sites with Benjamini-Hochberg– adjusted p-value < 0.1 and βCLIP:OEi > 0. The
above analysis was conducted using the edgeR package [80].
We found 1,097 unique targets that have at least one significant
MSI2-binding site (adjusted p-value < 0.1 with a corrected CLIP log fold change
of two or more). We observed the binding was distributed between the coding
sequence (CDS) and the UTRs (56% and 44%, respectively). We then queried the
MSigDB signatures with GSEA [126] using the full list of CLIP targets ranked
by fold change to understand the functional classification of MSI2’s targets.
MSI2 binding was positively enriched for 668 gene sets (FDR < 0.01). We
then examined the genes sets and categorized them into two modules, “RNA
regulation and electron transport” and “Signaling and development” based
on the overlaps between gene sets. For instance, within the “RNA regulation
and electron transport module”, genes sets containing genes that are normally
down-regulated after mTOR inhibition (i.e., rapamycin, leucine, or glutamine
deprivation) were enriched for MSI2 binding. These genes significantly overlap
with three other distinct gene sets including energy metabolism, mRNA
processing, and translation. In the “signaling and development module”, we
detected various pathways including gene sets related to “HSC versus CMP”
and “Self-renewal”, as well as other signaling pathways including TGFB1,
RAS and MYC. Altogether, these results indicate sophisticated roles of MSI2
in regulating multiple critical cellular processes and pathways.
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